Patients‘, relatives‘ and practitioners‘ views on pulmonary arterial hypertension

S. Alami, V. Cottin, D. Desjeux, L. Mouthon, S. Poiraudeau, E. Quessette, O. Sitbon (Paris, Lyon, Suresnes, Clamart, France)

Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Session: Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Session type: Thematic Poster Session
Number: 965
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Alami, V. Cottin, D. Desjeux, L. Mouthon, S. Poiraudeau, E. Quessette, O. Sitbon (Paris, Lyon, Suresnes, Clamart, France). Patients‘, relatives‘ and practitioners‘ views on pulmonary arterial hypertension. Eur Respir J 2012; 40: Suppl. 56, 965

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical outcomes of pulmonary arterial hypertension in carriers of ACVRL1 (ALK1) mutation
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009

Role of PPARγ in pulmonary hypertension and the relationship between PPARγ and PKC
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009

Cure pulmonary arterial hypertension associated with HIV (PAH-HIV)? … Toward an answer
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

HbA1c in pulmonary arterial hypertension – A marker of prognostic relevance?
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH and associated PH
Year: 2012

Evaluation of pulmonary diffusion: TLCO or KCO?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010

Drug-induced pulmonary arterial hypertension: a recent outbreak},
Source: Eur Respir Rev 2013; 22: 244-250
Year: 2013



The emerging problem of treating pulmonary M. avium complex (MAC) disease – microbial substitution of MAC to M. abscessus, Scedosporium and Nocardia after multi-drug chemotherapy in pulmonary MAC disease
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009

Airway resistances: Raw, sRaw, sReff – Which is the best determinant of airway function?
Source: Annual Congress 2010 - Lung function from infancy to adulthood
Year: 2010


Pulmonary arterial hypertension in children
Source: Eur Respir J 2003; 21: 155-176
Year: 2003



The right ventricle (RV) in systemic sclerosis-associated pulmonary arterial hypertension (SSCPH) vs idiopathic pulmonary arterial hypertension (IPH): higher inflammatory status, no increase in interstitial fibrosis
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

Pregnancy outcomes in pulmonary arterial hypertension in the modern management era},
Source: Eur Respir J 2012; 40: 881-885
Year: 2012



Pulmonary arterial hypertension: a comparison between children and adults
Source: Eur Respir J 2011; 37: 665-677
Year: 2011



Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?},
Source: Eur Respir Rev 2013; 22: 217-226
Year: 2013



Effects of pulmonary rehabilitation (PR) in idiopathic pulmonary arterial hypertension (PAHI)
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


Relationship between mean pulmonary artery pressure at rest and on mild exercise in subjects aged < 50 years and free of pulmonary hypertension
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010



Survival in pulmonary hypertension in Spain: insights from the Spanish registry},
Source: Eur Respir J 2012; 40: 596-603
Year: 2012



Is there a fixed relationship between the mean and systolic pulmonary artery pressures in idiopathic pulmonary arterial hypertension (IPAH) and proximal chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009

Thrombo-embolic pulmonary hypertension: which treatment should we choose? / Hypertension pulmonaire thrombo-embolique: quel traitement choisir ?
Source: International Congress 2018 – French Programme 2018: Part II
Year: 2018


Impact of pulmonary arterial hypertension (PAH) on the lives of patients and carers
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013


Formula for mean pulmonary arterial pressure in chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease
Year: 2009